ILC2-derived IL-9 activates regulatory T cells to facilitate post-myocardial infarction repair
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Group 2 innate lymphoid cells (ILC2s) are recognized as key innate immune effectors that facilitate early cardiac recovery after myocardial infarction (MI); however, the underlying mechanisms by which they mediate this repair remain largely unclear. METHODS: To investigate the role of ILC2-derived interleukin-9 (IL-9), we employed ILC2-specific IL-9 knockout mice and administered exogenous IL-9 in a murine MI model. The mechanism of regulatory T cells (Tregs) activation was further examined through Treg-specific Sirt1 knockout in vitro, focusing on STAT5 acetylation and related signaling. RESULTS: We demonstrate that ILC2-derived IL-9 is essential for post-MI repair by activating Tregs. IL-9 binding to the IL-9 receptor on Tregs upregulates the deacetylase Sirt1, and Sirt1 deletion abolishes IL-9-driven Treg activation. Furthermore, Sirt1 directly interacts with STAT5, promoting its deacetylation and phosphorylation, leading to the transcriptional activation of genes essential for Treg function. CONCLUSION: Our study identifies IL-9 as a key regulator of Treg activation via a novel Sirt1-STAT5 epigenetic pathway, which promotes tissue repair after MI. These findings reveal a previously unrecognized immunomodulatory axis with significant therapeutic potential for ischemic heart disease.
Fields of Study & Subjects
IL-33
ST2
and ILC Pathways
Cardiac Fibrosis and Remodeling
Congenital heart defects research
Publication details
- Journal / source
- Cell Communication and Signaling
- Volume
- 24
- Issue
- 1
- Publication date
- 27 March 2026
- Language
- EN